Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OFF-RAMP: Off-ramping Strategies for Maintaining Weight Loss
NCT07832084Phase 4Not yet recruiting
- Start
- Dec 2026
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of semaglutide, tirzepatide, phentermine and topiramate in obesity (3 arms). Primary endpoint: Feasibility of recruitment and retention at 12 months. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07832084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07832084.